1429643-39-9

Basic information

• Product Name: (R)-methyl 2-acetamido-3-(2-(3,3-dinitroazetidin-1-yl)-2-oxoethylthio)propanoate
• Synonyms: (R)-methyl 2-acetamido-3-(2-(3,3-dinitroazetidin-1-yl)-2-oxoethylthio)propanoate
• CAS NO: 1429643-39-9
• Molecular Weight: 364.336
• Mol File: 1429643-39-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (R)-methyl 2-acetamido-3-(2-(3,3-dinitroazetidin-1-yl)-2-oxoethylthio)propanoate(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-methyl 2-acetamido-3-(2-(3,3-dinitroazetidin-1-yl)-2-oxoethylthio)propanoate(1429643-39-9)
• EPA Substance Registry System: (R)-methyl 2-acetamido-3-(2-(3,3-dinitroazetidin-1-yl)-2-oxoethylthio)propanoate(1429643-39-9)

Safety Data

• Hazardous Substances Data: 1429643-39-9(Hazardous Substances Data)

Upstream product

• 925206-65-1 [14C]-Rrx-001 
• 7652-46-2 Ac-Cys-OMe 

Relevant articles and documents

Organonitro thioether compounds and medical uses thereof

The invention provides organonitro thioether compounds, compositions containing such compounds, isolated organonitro thioether compounds and methods for using such compounds and compositions to treat cancer in a patient. Exemplary organonitro thioether compounds described herein include 2-(3,3-dinitroazetidin-1-yl)-2-oxoethyl thioethers and variants thereof. Another aspect of the invention provides a pharmaceutical composition, comprising a pharmaceutically acceptable carrier and an organonitro thioether compound described herein, such as a compound of Formula I or II. Another aspect of the invention provides a method of treating cancer in a patient. The method comprises administering to a patient in need thereof a therapeutically effective amount of an organonitro thioether compound described herein, such as a compound of Formula I or II, to treat the cancer.